LogD_7.4

About the Assay

Sygnature Discovery’s LogD_7.4 assay quantifies compound lipophilicity using a classical shake‑flask partitioning approach between 1‑octanol and pH 7.4 phosphate buffer. Lipophilicity expressed as the Log of the distribution coefficient (LogD), is a key determinant of solubility, distribution, permeability and metabolic stability, making its accurate measurement essential for early‑stage drug discovery. The assay is designed to provide reliable LogD measurements across a broad chemical diversity, from hydrophilic to highly lipophilic compounds.

Protocol Summary

The LogD_7.4 workflow involves partitioning of test compounds between 1-octanol and pH 7.4 buffer to quantify the relative distribution between polar and non‑polar environments. Test compound solutions utilizing 10 mM DMSO stocks are prepared in 1-octanol, equilibrated to ensure complete dissolution, and mixed with buffer in a defined phase ratio. Mechanical shaking ensures efficient mixing and enables the compound to distribute between the two phases.

Once equilibrium is reached, the two phases are separated by centrifugation, and aliquots are taken from each layer. Samples undergo appropriate dilution to fall within the analytical calibration range, and quantification is performed using LC–MS/MS. Measurements from multiple dilutions of buffer samples and nominal octanol standards are combined to generate a set of LogD ratios, from which accepted values are averaged to provide a final reported LogD_7.4.

This structured workflow emphasizes reproducibility, minimizes handling variability and supports consistent data across compound classes. The standardised dilution and calibration strategy ensures robust quantification, enabling confident assessment of compounds spanning a wide range of lipophilicities.

Validation Results

Figure 1. Graph illustrating the mean measured LogD values for reference compounds vs literature data ^(1,2,3) in pH7.4 phosphate buffer:1-octanol

A subset of five compounds was further assessed in a dedicated intra‑assay evaluation (n = 6 incubations). The results demonstrated outstanding consistency, with coefficients of variation ranging from 0.9% to 8.7%, confirming reproducible performance within a single experimental run.

Summary

The assay delivers robust and reproducible partitioning across two immiscible phases following controlled equilibration, enabling accurate determination of concentration ratios. LC–MS/MS quantification ensures high sensitivity and broad dynamic range, supporting measurement of both polar and lipophilic molecules. The method supports high confidence in LogD_7.4 characterization, facilitating medicinal chemistry optimization and enabling reliable structure‑property relationship interpretation.

Overall, the shake‑flask LogD_7.4 assay provides high‑quality lipophilicity data aligned with industry standards and literature values, making it a powerful tool within early‑stage ADME screening workflows.

References

1. F. Lombardo, M.Y.Shaleva, K.A.Tupper, F.Gao, A tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds, J. Med. Chem. 44 (2001) 2490-2497
2. G. Morikawa, C. Suzuka, A. Shoji, Y. Shibusawa, A. Yanagida, High-throughput determination of octanol/water partition coefficients using a shake-flask method and novel two-phase solvent system. Journal of Pharmaceutical and Biomedical Analysis 117 (2019) 338-344
3. M. Wenlock, T. Potter, P. Barton, and R.P. Austin, A Method for Measuring the Lipophilicity of Compounds in Mixtures of 10. Society for Laboratory Automation and Screening (2011)